PDT Partners’s NeoGenomics NEO Stock Holding History

PDT Partners’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-14,554	Closed	-$537K	–	802
2020 Q3	$537K	Buy	14,554 +7,566	+108%	+$281K	0.04%	433
2020 Q2	$216K	Buy	+6,988	New	+$194K	0.01%	585

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

PDT Partners's NEO Position: Q4 2020 in Review

PDT Partners sold out of NeoGenomics (NEO) in Q4 2020, closing a stake of 14,554 shares — an estimated $537K sold.

PDT Partners first reported a position in NEO in Q2 2020 and held it in 2 quarters. The position peaked at $537K in Q3 2020. 340 funds tracked by Wall St. Rank hold NEO as of Q4 2020.

PDT Partners reported no remaining NeoGenomics position as of Q4 2020 after selling out during the quarter.
PDT Partners sold 14,554 NeoGenomics shares in Q4 2020, an estimated $537K.
PDT Partners first reported a position in NeoGenomics in Q2 2020 and held it in 2 quarters.
PDT Partners's NeoGenomics position peaked at $537K in Q3 2020.
340 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2020.

Based on PDT Partners's 13F filing for Q4 2020, filed 16 Feb 2021.